{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:11:09Z","timestamp":1788793869179,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Cytochrome P450 enzyme metabolism is altered by environmental and genetic factors, which can affect the efficacy and safety of opioids. This article describes CYP polymorphisms and how pharmacogenetic testing could be used to help clinicians make safer decisions about opioid use in patients.<\/jats:p>","DOI":"10.1097\/01.jaa.0000947084.60262.4e","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:01:53Z","timestamp":1693922513000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Maximizing patient safety when prescribing opioids for pain management"],"prefix":"10.1097","volume":"36","author":[{"given":"Megan","family":"Judy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephon","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-20250605","first-page":"1423","article-title":"Pain polymorphisms and opioids: an evidence based review","volume":"19","author":"Vieira","year":"2019","journal-title":"Mol Med Rep"},{"issue":"3","key":"R2-20250605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/03602532.2018.1483401","article-title":"Human cytochrome P450 enzymes 5\u201351 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition--toxic effects and benefits","volume":"50","author":"Rendic","year":"2018","journal-title":"Drug Metab Rev"},{"issue":"1","key":"R3-20250605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40122-017-0069-2","article-title":"Genetic testing for opioid pain management: a primer","volume":"6","author":"Agarwal","year":"2017","journal-title":"Pain Ther"},{"issue":"1","key":"R4-20250605","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.sjpain.2017.09.009","article-title":"Individual variability in clinical effect and tolerability of opioid analgesics \u2013 importance of drug interactions and pharmacogenetics","volume":"17","author":"Solhaug","year":"2017","journal-title":"Scand J Pain"},{"issue":"8","key":"R5-20250605","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.114.057836","article-title":"Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As","volume":"42","author":"El-Sherbeni","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"R9-20250605","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/pgs-2017-0033","article-title":"Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing","volume":"18","author":"Yang","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"5","key":"R10-20250605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.9740\/mhc.2018.09.235","article-title":"Overview of pharmacogenomic testing in clinical practice","volume":"8","author":"Gross","year":"2018","journal-title":"Ment Health Clin"},{"key":"R11-20250605","article-title":"Pharmacogenetics and pain management: an opportunity to advance personalized patient care","author":"Chianta"},{"issue":"50\u201351","key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"E611","DOI":"10.36076\/ppj.2018.6.E611","article-title":"Fundamental considerations for genetically-guided pain management with opioids based on CYP2D6 and OPRM1 polymorphisms","volume":"21","author":"Ruano","year":"2018","journal-title":"Pain Physician"},{"issue":"4","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1373\/jalm.2017.025304","article-title":"Using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J Appl Lab Med"},{"key":"R21-20250605","first-page":"179","article-title":"CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort","volume":"11","author":"Dagostino","year":"2018","journal-title":"Pharmgenomics Pers Med"},{"issue":"4","key":"R22-20250605","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2019.05.002","article-title":"Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients","volume":"65","author":"Gallo","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"1","key":"R24-20250605","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-016-3810-3","article-title":"Association between initial opioid prescribing patterns and subsequent long-term use among opioid-na\u00efve patients: a statewide retrospective cohort study","volume":"32","author":"Deyo","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"4","key":"R25-20250605","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update","volume":"95","author":"Crews","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"R26-20250605","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annemergmed.2015.11.033","article-title":"Emergency department prescription opioids as an initial exposure preceding addiction","volume":"68","author":"Butler","year":"2016","journal-title":"Ann Emerg Med"},{"issue":"suppl 1","key":"R28-20250605","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.4103\/0976-500X.120957","article-title":"Clinical and economic burden of adverse drug reactions","volume":"4","author":"Sultana","year":"2013","journal-title":"J Pharmacol Pharmacother"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000947084.60262.4e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:03:43Z","timestamp":1749153823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000947084.60262.4e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000947084.60262.4e","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}